LATISSE™ (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or sparse eyelashes, growing them longer, fuller and darker. 

LATISSE™ makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests LATISSE™ is effective and FDA approved. It's a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12 to 16 weeks.

While LATISSE™ is a new treatment for inadequate or meager eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.